lobbying_activities: 2467200

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2467200 d030d77f-55ae-440f-a478-a6a343150d37 Q2 MEHLMAN CONSULTING, INC. 284950 ASSOCIATION OF ACCESSIBLE MEDICINES 2020 second_quarter PHA Medicaid and Medicare drug pricing. Prescription drug pricing. S.1895 - Lower Health Care Costs Act. H.R. 938 - BLOCKING Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act of 2019 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2020-07-15T20:15:50.177000-04:00